Lead sponsor
Phoenix VA Health Care System
2 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
2
Trials led
0
Active
245
Total enrollment
2
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 4
2
Trials by status
Completed
1
Unknown
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes MellitusHbA1c 6.5-10%Ph 4Unknown148
The Effect of Liraglutide on Dietary Lipid Induced Insulin Resistance in HumansBMI 22-35Ph 4Completed97